SELECTBIO brings to you its 3rd International conference on ADC Development & Manufacture "Antibodies and Antibody Drug Conjugates" on May 24-25, 2018 in Bengaluru, India.
An innovative therapeutic application which combines the distinctive properties of monoclonal antibodies (mAbs) with the potent cytotoxic effect of small drug molecules is Antibody-drug conjugates or ADCs. This conference will be covering different aspects of ADC development and manufacture, right from the introduction to regulatory thereby ensuring comprehensive understanding of the subject. In addition this event will provide an excellent platform for knowledge sharing, collaborative research and networking with the scientists in the field of Antibody Engineering, Antibody drug conjugates, biopharmaceuticals and Cancer research.
This event is co-located with our International Conference Biomarkers & Diagnostics. Running alongside the conferences will be an exhibition covering the latest advancements in the instrumentation for antibody and cell technologies related research and development.
Venue and Date: Bengaluru, May 24-25, 2018
Sponsorship Options: Companies willing to participate in this event as Sponsors should contact the Exhibition Manager. Sponsorship options with Delegate Participation are also available.
Call for Papers
If you would like to be considered for an oral presentation at this meeting, Submit an abstract for review now!
Oral Presentation Submission Deadline: 31 January 2018
Call for Posters
You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!
Poster Submission Deadline: 28 February 2018
ADC Development - Issues and Challenges
Antibody Development & Engineering
Bioanalytical Strategies for ADCs
Novel Conjugation Technologies, Payload & Linkers
Strategies for Development of Specific and Targeted ADCs
Sponsorship and Exhibition Opportunities
Maninderjit Singh, Exhibition Manager